Evidence map›Paper›PMID 34788174›Full record

ArticleJournal of neurophysiology2022

PV-specific loss of the transcriptional coactivator PGC-1α slows down the evolution of epileptic activity in an acute ictogenic model.

Connie Mackenzie-Gray Scott, R Ryley Parrish, Darren Walsh, Claudia Racca, Rita M Cowell, Andrew J Trevelyan

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Connie Mackenzie-Gray ScottMedical School, Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.ORCID 0000-0001-7962-8906
R Ryley ParrishMedical School, Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.
Darren WalshMedical School, Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.ORCID 0000-0002-8010-8067
Claudia RaccaMedical School, Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.
Rita M CowellDepartment of Neuroscience, Drug Discovery Division at Southern Research, Birmingham, Alabama.
Andrew J TrevelyanMedical School, Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.ORCID 0000-0001-9307-4241
Newcastle University · GBSouthern Research Institute · US

Funding

Medical Research Council MR/R005427/1Wellcome Trust
6 · The paper itself

Abstract

The transcriptional coactivator, PGC-1α (peroxisome proliferator-activated receptor γ coactivator 1α), plays a key role in coordinating energy requirement within cells. Its importance is reflected in the growing number of psychiatric and neurological conditions that have been associated with reduced PGC-1α levels. In cortical networks, PGC-1α is required for the induction of parvalbumin (PV) expression in interneurons, and PGC-1α deficiency affects synchronous GABAergic release. It is unknown, however, how this affects cortical excitability. We show here that knocking down PGC-1α specifically in the PV-expressing cells (PGC-1α

Indexed as

AnimalsCortical ExcitabilityDisease Models, AnimalFemaleInterneuronsMaleMiceMice, Inbred C57BLMice, KnockoutNeocortexParvalbuminsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPyramidal CellsSeizuresParvalbuminsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseneocortexparvalbuminPGC-1αpreictalseizure

Identifiers

PMID34788174
PMCPMC8721902
OpenAlexW3212179860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.